Overexpression of COL3A1 confers a poor prognosis in human bladder cancer identified by co-expression analysis

Lushun Yuan,Bo Shu,Liang Chen,Kaiyu Qian,Yongzhi Wang,Guofeng Qian,Yuan Zhu,Xinyue Cao,Conghua Xie,Yu Xiao,Xinghuan Wang

DOI: https://doi.org/10.18632/oncotarget.19733

2017-07-28

Oncotarget

Abstract:Human bladder cancer (BCa) is one of the worldwide cancers in men and women populations, with the etiology and mechanism unknown. In our study, we constructed a weighted gene co-expression network to identify gene modules associated with the progression of BCa (n = 93). In the significant module (R² = 0.48), a total of 103 network hub genes were identified, and 4 of them were hub nodes in the protein-protein interaction network as well. In validation, <i>COL3A1</i> showed a higher correlation with the disease progression than any other hub genes in hub module in the test set (p &lt; 0.001). Functional and pathway enrichment analysis demonstrated that <i>COL3A1</i> is overrepresented in pathway of focal adhesion, which associated with tumor progression and might cause metastasis. Gene set enrichment analysis (GSEA) also demonstrated that the gene set of "MAPK signaling pathway" and focal adhesion related pathways were enriched in BCa samples with <i>COL3A1</i> highly expressed (FDR &lt; 0.05). Considering the clinicopathological parameters, highly-expressed <i>COL3A1</i> was closely correlated with local recurrence and BCa stage. Survival analysis revealed that BCa patients with higher expression of <i>COL3A1</i> had a significantly shorter overall survival time and disease free survival time.In conclusion, based on the co-expression analysis, <i>COL3A1</i> was identified in the association with progression and prognosis of BCa, which might refer a poor prognosisprobably by regulating MAPK signaling pathway.